JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Pogam, S.
Right arrow Articles by Goudeau, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Pogam, S.
Right arrow Articles by Goudeau, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 1998, p. 1461-1463, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Comparison of DNA Enzyme Immunoassay and Line Probe Assays (Inno-LiPA HCV I and II) for Hepatitis C Virus Genotyping

S. Le Pogam,1 F. Dubois,1,2 R. Christen,3 C. Raby,1 A. Cavicchini,4 and A. Goudeau1,*

Département de Microbiologie Médicale et Moléculaire, CNRS EP 117-CHU Bretonneau, 37044 Tours Cedex,1 Institut Régional pour la Santé, 37521 La Riche Cedex,2 and Observatoire Océanologique-Station Zoologique, CNRS and Université Pierre et Marie Curie, 06230 Villefranche-sur-Mer Cedex,3 France, and Diagnostics Division, SORIN Biomedica, 13040 Saluggia (VC), Italy4

Received 28 October 1997/Returned for modification 22 December 1997/Accepted 9 February 1998

Two methods for genotyping hepatitis C virus (DNA enzyme immunoassay [DEIA] and line probe assay [Inno-LiPA HCV I and II]) were compared on 120 samples and of these 87% were assigned to the same subtype by both assays. There were 15 subtyping discrepancies which involved 5% of type 1 isolates and 90% of type 2 isolates. Amplified products from the core and 5' untranslated regions (UTR) were sequenced to resolve conflicts. Type 1 discordant samples had a guanosine at position -99 in the 5' UTR, a characteristic of genotype 1b, and a core region typical of subtype 1a. The eight isolates classified as 2a/2c by LiPA and as subtype 2c by DEIA belonged to type 2.

* Corresponding author. Mailing address: Département de Microbiologie Médicale et Moléculaire CNRS EP 117-CHU Bretonneau, 2 Boulevard Tonnellé, 37044 Tours Cedex, France. Phone: (33) 2 47 47 69 97. Fax: (33) 2 47 47 36 10. E-mail: gondeau{at}med.univ-tours.fr.

Journal of Clinical Microbiology, May 1998, p. 1461-1463, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1998 by the American Society for Microbiology. All rights reserved.